Pulmatrix Stock Technical Analysis
| PULM Stock | USD 2.44 0.02 0.81% |
As of the 16th of February 2026, Pulmatrix holds the Risk Adjusted Performance of (0.09), variance of 36.39, and Coefficient Of Variation of (779.27). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulmatrix, as well as the relationship between them. Please check Pulmatrix information ratio and skewness to decide if Pulmatrix is priced some-what accurately, providing market reflects its current price of 2.44 per share. Please also confirm Pulmatrix jensen alpha, which is currently at (0.81) to check out the company can sustain itself at a future point.
Pulmatrix Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pulmatrix, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PulmatrixPulmatrix | Build AI portfolio with Pulmatrix Stock |
Will Pharmaceuticals sector continue expanding? Could Pulmatrix diversify its offerings? Factors like these will boost the valuation of Pulmatrix. Anticipated expansion of Pulmatrix directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulmatrix data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pulmatrix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulmatrix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pulmatrix's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Pulmatrix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pulmatrix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pulmatrix.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Pulmatrix on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Pulmatrix or generate 0.0% return on investment in Pulmatrix over 90 days. Pulmatrix is related to or competes with Dare Bioscience, Hoth Therapeutics, Aspire BioPharma, Palisade Bio, Aditxt, Curis, and FibroBiologics Common. Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat r... More
Pulmatrix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pulmatrix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pulmatrix upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 51.95 | |||
| Value At Risk | (5.75) | |||
| Potential Upside | 6.62 |
Pulmatrix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pulmatrix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pulmatrix's standard deviation. In reality, there are many statistical measures that can use Pulmatrix historical prices to predict the future Pulmatrix's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | (1.63) |
Pulmatrix February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.62) | |||
| Mean Deviation | 3.31 | |||
| Coefficient Of Variation | (779.27) | |||
| Standard Deviation | 6.03 | |||
| Variance | 36.39 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | (1.63) | |||
| Maximum Drawdown | 51.95 | |||
| Value At Risk | (5.75) | |||
| Potential Upside | 6.62 | |||
| Skewness | (3.06) | |||
| Kurtosis | 19.97 |
Pulmatrix Backtested Returns
Pulmatrix maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Pulmatrix exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pulmatrix's Coefficient Of Variation of (779.27), risk adjusted performance of (0.09), and Variance of 36.39 to confirm the risk estimate we provide. The company holds a Beta of 0.48, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pulmatrix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pulmatrix is expected to be smaller as well. At this point, Pulmatrix has a negative expected return of -0.77%. Please make sure to check Pulmatrix's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Pulmatrix performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.02 |
Very weak reverse predictability
Pulmatrix has very weak reverse predictability. Overlapping area represents the amount of predictability between Pulmatrix time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pulmatrix price movement. The serial correlation of -0.02 indicates that only 2.0% of current Pulmatrix price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | -0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Pulmatrix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Pulmatrix Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pulmatrix volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Pulmatrix Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pulmatrix on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pulmatrix based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pulmatrix price pattern first instead of the macroeconomic environment surrounding Pulmatrix. By analyzing Pulmatrix's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pulmatrix's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pulmatrix specific price patterns or momentum indicators. Please read more on our technical analysis page.
Pulmatrix February 16, 2026 Technical Indicators
Most technical analysis of Pulmatrix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pulmatrix from various momentum indicators to cycle indicators. When you analyze Pulmatrix charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.62) | |||
| Mean Deviation | 3.31 | |||
| Coefficient Of Variation | (779.27) | |||
| Standard Deviation | 6.03 | |||
| Variance | 36.39 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | (1.63) | |||
| Maximum Drawdown | 51.95 | |||
| Value At Risk | (5.75) | |||
| Potential Upside | 6.62 | |||
| Skewness | (3.06) | |||
| Kurtosis | 19.97 |
Pulmatrix February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Pulmatrix stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (0.22) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 2.49 | ||
| Day Typical Price | 2.47 | ||
| Price Action Indicator | (0.05) | ||
| Market Facilitation Index | 0.09 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Will Pharmaceuticals sector continue expanding? Could Pulmatrix diversify its offerings? Factors like these will boost the valuation of Pulmatrix. Anticipated expansion of Pulmatrix directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulmatrix data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pulmatrix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulmatrix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pulmatrix's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.